| Literature DB >> 32046683 |
Amirabbas Mofidi1,2, Emile Tompa1,3, Seyed Bagher Mortazavi4,5, Akbar Esfahanipour6, Paul A Demers7.
Abstract
BACKGROUND: Construction workers are at a high risk of exposure to various types of hazardous substances such as crystalline silica. Though multiple studies indicate the evidence regarding the effectiveness of different silica exposure reduction interventions in the construction sector, the decisions for selecting a specific silica exposure reduction intervention are best informed by an economic evaluation. Economic evaluation of interventions is subjected to uncertainties in practice, mostly due to the lack of precise data on important variables. In this study, we aim to identify the most cost-beneficial silica exposure reduction intervention for the construction sector under uncertain situations.Entities:
Keywords: Bayesian networks; Cost-benefit analysis; Lung cancer; Net benefit; Probabilistic modeling approach; Uncertainty
Year: 2020 PMID: 32046683 PMCID: PMC7014628 DOI: 10.1186/s12889-020-8307-7
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Steps of a Probabilistic Modeling Approach for Economic Evaluation of Silica Exposure Reduction Interventions
Fig. 2A Simplified Representation of Economic Evaluation Model of Silica Exposure Reduction Interventions, Using Bayesian Network. Note. Ellipses represent random variables, rectangles represent silica exposure reduction intervention options as decision variables, and hexagons represent costs as values or utility nodes, Interventions: wet method (WM), local exhaust ventilation (LEV), personal protective equipment (PPE), and combinates of the following: WM-LEV-PPE, WM-LEV, WM-PPE, LEV-PPE, primary silica exposure: level of exposure to silica dust before an intervention, effectiveness: reduction ability of silica exposure interventions, coverage: percentage of silica-exposed workers that a specific intervention is applicable to, unit cost: cost of implementation of an intervention, direct costs: sum of healthcare, informal care, and out-of-pocket costs of lung cancer cases. Indirect cost: sum of output/productivity losses and home production losses of lung cancer cases, intangible cost: monetary value of health-related quality of the life losses of lung cancer case
Expected Costs and Benefits of Silica Exposure Reduction Interventions
| Interventions | WM-LEV-PPE | WM-LEV | WM-PPE | WM | LEV-PPE | LEV | PPE |
|---|---|---|---|---|---|---|---|
| Protected workersa | 100% | 100% | 100% | 60% | 100% | 40% | 100% |
| Lung cancer cases avertedb | 107 | 95 | 102 | 55 | 101 | 40 | 96 |
| Direct | $9.5 M | $8.4 M | $9.0 M | $4.9 M | $8.9 M | $3.5 M | $8.6 M |
| Indirect | $41.2 M | $36.6 M | $39.3 M | $21.1 M | $38.8 M | $15.3 M | $37.1 M |
| Intangible | $133.9 M | $119.1 M | $127.6 M | $68.6 M | $126.0 M | $49.7 M | $120.7 M |
| Total | $184.5 M | $164.2 M | $175.9 M | $94.5 M | $173.8 M | $68.5 M | $166.4 M |
| WMc | -$42.0 M | -$42.0 M | -$42.0 M | -$42.0 M | $0 | $0 | $0 |
| LEVd | -$15.5 M | -$15.5 M | $0 | $0 | -$15.5 M | -$15.5 M | $0 |
| PPEe | -$81.1 M | $0 | -$81.1 M | $0 | -$81.1 M | $0 | -$81.1 M |
| Total | -$138.6 M | -$57.6 M | -$123.1 M | -$42.0 M | -$96.6 M | -$15.5 M | -$81.1 M |
| Net benefitf | $45.9 M | $106.6 M | $52.8 M | $52.5 M | $77.2 | $53.0 M | $85.3 M |
| Benefit to cost ratiog | 1.3 | 2.9 | 1.4 | 2.2 | 1.8 | 4.4 | 2.1 |
Note. aPercentage of the silica-exposed workers in construction sector that are protected by each intervention, bexpected number of the occupational lung cancer cases averted, ctotal cost of implementing WM, dtotal cost of implementing LEV, etotal cost of implementing PPE, fdifference between cost of lung cancer cases averted and cost of intervention, gcalculated by dividing the total benefits by the total costs of an intervention. Due to rounding, columns, and rows may not sum to 100%, All table monetary values are in 2017 Canadian dollars
Sensitivity Analysis of Interventions for Different Numbers of Silica-Exposed Workers and Different Levels of Exposure
| Primary silica exposure | Baseline | Low Exposure (< 0.0125 mg/m3) | Medium Exposure (0.0125–0.025 mg/m3) | High Exposure (> 0.025 mg/m3) | |||
|---|---|---|---|---|---|---|---|
| Silica-exposed workersa | Lower bound | Upper bound | Lower bound | Upper bound | Lower bound | Upper bound | |
| 91 | 46 | 118 | 46 | 118 | 46 | 118 | |
| Expected LC casesb | 110 | 60 | 111 | 80 | 140 | 95 | 180 |
| Total LC costsc | $189 M | $103 M | $191 M | $138 M | $241 M | $164 M | $310 M |
| LC cases avertedd | 107 | 60 | 111 | 79 | 138 | 84 | 162 |
| Total LC costs avertede | $185 M | $103 M | $191 M | $136 M | $238 M | $145 M | $280 M |
| Total intervention costsf | $151 M | $99 M | $173 M | $99 M | $173 M | $99 M | $173 M |
| Net benefitg | $46 M | $4 M | $19 M | $37 M | $65 M | $46 M | $107 M |
| Net benefit change (%) | – | 10% | 41% | 80% | 142% | 100% | 233% |
| LC cases avertedd | 95 | 60 | 111 | 71 | 124 | 46 | 100 |
| Total LC costs avertede | $164 M | $103 M | $191 M | $122 M | $214 M | $79 M | $172 M |
| Total intervention costsf | $63 M | $43 M | $71 M | $43 M | $71 M | $43 M | $71 M |
| Net benefitg | $107 M | $60 M | $120 M | $79 M | $143 M | $36 M | $101 M |
| Net benefit change (%) | – | 57% | 113% | 74% | 134% | 34% | 95% |
| LC cases avertedd | 96 | 59 | 109 | 73 | 129 | 57 | 113 |
| Total LC costs avertede | $166 M | $101 M | $187 M | $126 M | $222 M | $97 M | $195 M |
| Total intervention costsf | $81 M | $56 M | $101 M | $56 M | $101 M | $56 M | $101 M |
| Net benefitg | $85 M | $45 M | $86 M | $70 M | $120 M | $42 M | $94 M |
| Net benefit change (%) | – | 53% | 101% | 83% | 141% | 49% | 110% |
Note. anumber of the silica-exposed workers in the construction sector in thousand, bexpected occupational lung cancer cases,ctotal cost of occupational lung cancer cases with no intervention, dexpected occupational lung cancer cases averted after implementation of an intervention, etotal cost of lung cancer cases averted, fcost of implementing a silica exposure reduction intervention, gdifference between cost of lung cancer cases averted and cost of intervention. All table monetary values are in 2017 Canadian dollars